Melanoma brain metastases – Interdisciplinary management recommendations 2020-Reference-Cited by-同舟云学术

Melanoma brain metastases – Interdisciplinary management recommendations 2020

Published:2020-09 Issue: Volume:89 Page:102083
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Gutzmer Ralf,Vordermark Dirk,Hassel Jessica C.,Krex Dietmar,Wendl Christina,Schadendorf Dirk,Sickmann Thomas,Rieken Stefan,Pukrop Tobias,Höller Christoph,Eigentler Thomas K.^ORCID,Meier Friedegund

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference130 articles.

1. Melanoma;Schadendorf;Lancet,2018

2. Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience;Madajewicz;Cancer,1984

3. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials;Gaspar;Int J Radiat Oncol Biol Phys,1997

4. Determinants of outcome in melanoma patients with cerebral metastases;Fife;J Clin Oncol,2004

5. Prognostic factors for survival in melanoma patients with brain metastases;Davies;Cancer,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening;Pharmaceutics;2024-08-05

2. Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literature;Journal of Gastrointestinal Oncology;2024-06

3. Establishment and validation of a nomogram model for predicting the specific mortality risk of melanoma in upper limbs based on the SEER database;Scientific Reports;2024-04-26

4. Vascular mimicry as a facilitator of melanoma brain metastasis;Cellular and Molecular Life Sciences;2024-04-18

5. Efficiency and tolerance of second-line triple BRAF inhibitor/MEK inhibitor/anti-PD1 combined therapy in BRAF mutated melanoma patients with central nervous system metastases occurring during first-line combined targeted therapy: a real-life survey;Melanoma Research;2024-03-28